dar-901
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2014 (NCT02063555)
Timeline
Indications
Studied for
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dar-901
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02712424 | Phase 2 | Mar 1, 2016 | Dartmouth University, Muhimbili University |
| NCT02063555 | Phase 1 | Feb 1, 2014 | Aeras, Dartmouth University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Dartmouth University | Academic/Hospital | 2 | 2 | 2 | 2014 |
| Aeras | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Muhimbili University | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1